Page last updated: 2024-09-04

levofloxacin and Infections, Respiratory

levofloxacin has been researched along with Infections, Respiratory in 119 studies

Research

Studies (119)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	21 (17.65)	18.2507
2000's	53 (44.54)	29.6817
2010's	37 (31.09)	24.3611
2020's	8 (6.72)	2.80

Authors

Authors	Studies
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH	1
Baba, S; Billal, DS; Fujihara, K; Hotomi, M; Nishimura, T; Suzuki, K; Yamanaka, N	1
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM	1
Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D	1
Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J	1
Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P	1
Achorn, C; Chen, CL; Clark, RB; Deng, Y; Fyfe, C; Grossman, TH; He, M; Hogan, PC; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sutcliffe, JA; Xiao, XY; Zhu, Z	1
Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H	1
Inagaki, H; Kitamura, T; Komoriya, S; Nagamochi, M; Odagiri, T; Takahashi, H	1
Bhagwat, S; Bhawsar, S; Deshpande, P; Joshi, S; Patel, M; Yeole, R	1
Crumrine, M; Hewitt, JA; Slay, RM	1
Wu, M; Yang, D	1
Alvear, G; Martínez, B; Ramírez, V; Santibáñez, L; Sepúlveda, R	1
Alcalá, FJC; Alonso, AR; Alonso, OZ; Calvo, C; de Villalta, MGF; García, LE; García-Boyano, M; Melero, IQ; Retolaza, IR	1
Griffith, DC; Sabet, M	1
Kovalenko, T; Krasnikova, L; Mishyna, M; Shtaniuk, E; Vovk, O	1
Areej, S; Javeed, A; Raza, S; Sattar, A	1
Hu, P; Zhang, L	1
Burillo-Martínez, S; Maroñas-Jiménez, L; Prieto-Barrios, M; Tous-Romero, F	1
Fujisaki, S; Kashiwa, M; Muto, S; Saito, R; Tamamori, Y; Yamada, K	1
Carpenter, S; Henning, LN; Serbina, NV; Stark, GV	1
Gupta, PV; Nagarsenker, MS; Nirwane, AM	1
Chen, L; Luo, Z; She, P; Wu, Y	1
Barrado, L; Ezpeleta-Baquedano, C; Navascués, A; Torroba-Álvarez, L	1
Chatzika, K; Kioumis, I; Kontou, P; Manika, K; Papaioannou, M; Pitsiou, G; Sionidou, M	1
Bruguera, M; Forns, X; García Juárez, I; Miquel, R	1
Chang, SW; Chen, PR; Kuo, HY; Liou, ML; Liu, CC; Pien, CJ; Yeh, HW	1
Comer, J; Kammanadiminti, S; Kodihalli, S; Meister, G; Patnaikuni, RK; Sinclair, C	1
Ardanuy, C; Calatayud, L; de la Campa, AG; Garmendia, J; Liñares, J; Marti, S; Puig, C; Tirado-Vélez, JM; Tubau, F	1
Ampofo, K; Hillyard, B; Sherwin, CM; Spigarelli, MG; Stockmann, C	1
Carral, N; Lukas, JC; Oteo, I; Suarez, E	1
Bolmer, S; Buccellato, M; Corey, A; Meister, G; Migone, TS; Vasconcelos, D; Zhong, J	1
Cao, B; Chen, R; Du, Y; Hu, B; Hu, Y; Liu, Y; Liu, Z; Su, D; Sun, H; Wang, H; Wang, Z; Xu, X; Zhang, F; Zhang, R; Zhao, C; Zhuo, C	1
Chen, L; Chen, X; Jia, X; Li, N; Liu, W; Sun, H; Tong, H; Xiang, R; Xu, Y; Zhang, F; Zhang, J; Zhao, H	1
Cohen, F; Elborn, JS; Flume, PA; Loutit, J; VanDevanter, DR	1
John, F; Oluronbi, R; Pitchumoni, CS	1
Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Park, GE; Peck, KR; Seok, HR; Song, JH	1
Couderc, L; Lémée, L; Marguet, C; Morisse-Pradier, H	1
Rapp, RP	1
Chen, BY; Ding, GH; Duan, J; Gu, JM; Guo, DY; Hao, QL; Huang, HH; Huang, JA; Li, HY; Li, QH; Liu, A; Lü, XJ; Ma, H; Ren, ZY; Shen, HH; Shi, MH; Si, B; Sun, SH; Sun, TY; Wu, GM; Xia, QM; Xiao, W; Xiao, ZK; Xiu, QY; Yang, HF; Yang, HP; Yao, WZ; Ying, KJ; Yu, YS; Yue, HM; Zhang, W; Zhang, YY; Zheng, HG	1
Aihara, M; Akiyama, T; Akizawa, K; Aoki, Y; Asano, Y; Baba, H; fujimoto, Y; Fujita, J; Fujita, S; Fujiwara, H; Genma, H; Gonda, H; Haruki, K; Hashikita, G; Hayashi, M; Heijyou, H; Hida, Y; Hiramatsu, K; Horiuchi, H; Ichiyama, S; Idomuki, M; Ieiri, T; Ikeda, N; Inuzuka, K; Iriyama, J; Ishii, Y; Ito, T; Iwata, M; Kaku, M; Kamioka, M; Kanda, M; Kang, D; Kanno, H; Katayama, Y; Kato, J; Kawahara, K; Kawamura, C; Kawano, S; Kawashima, C; Kinoshita, S; Kobayashi, Y; Kohno, S; Koike, K; Kon, S; Kondou, S; Kono, H; Kumasaka, K; Kusaba, K; Kusakabe, T; Kusano, N; Kuwabara, M; Maekawa, M; Maesaki, S; Masaki, H; Mashiba, K; Matsuda, J; Matsuda, K; Matsuo, S; Miki, M; Misawa, S; Miyajima, E; Miyanohara, H; Moro, K; Murakami, M; Murase, M; Murata, M; Nagai, A; Nakagawa, T; Nakamura, K; Nakashima, Y; Nakasone, I; Nakatani, K; Nakaya, H; Negayama, K; Ohno, A; Oka, M; Okabe, H; Okada, M; Okamoto, H; Okamoto, Y; Okayama, A; Okazaki, T; Okubo, S; Ono, J; Ota, H; Ozaki, Y; Saikawa, T; Saito, T; Sano, R; Sekine, I; Shigeta, M; Shimizu, C; Shiotani, J; Soma, M; Sugita, A; Sugiura, T; Sumitomo, M; Suwabe, A; Takubo, T; Taniguchi, N; Tashiro, H; Tateda, K; Tazawa, Y; Tominaga, M; Toyoshima, S; Uchida, T; Yamaguchi, I; Yamaguchi, K; Yamahata, K; Yamamoto, G; Yamamoto, Y; Yamane, N; Yamashita, M; Yamazaki, K; Yanagihara, K; Yasujima, M; Yoneyama, A; Yoshida, H; Yoshimura, H; Yuzuki, Y	1
Cao, GY; Chen, YQ; Shi, YG; Wu, XJ; Xie, X; Yu, JC; Zhang, J; Zhang, YY; Zhou, X	1
Eaves-Pyles, TD; Jezek, GE; Pyles, RB	1
De Vecchi, E; Drago, L; Mattina, R; Nicola, L	1
Pea, F	1
Finley, R; Glass, SK; McEwen, SA; Pearl, DL	1
Myskowski, PL; Parashar, B; Swistel, AJ; Wernicke, AG	1
Płusa, T	1
Malithong, A; Phiboonbanakit, D; Santiwatanakul, S; Srisangchan, P; Srisurat, N; Susaengrat, W; Tantisiriwat, W; Thamlikitkul, V; Thunyaharn, S; Tiengrim, S	1
Liapikou, A; Torres, A	1
Bourdage, JS; Duchars, M; Fuerst, TR; Fusco, PC; Leffel, EK; Williamson, ED	1
Chen, Y; Huang, W; Li, Q; Lu, G; Lv, X; Sun, Y; Wu, G; Wu, X; Wu, Y; Yang, H; Zhang, G	1
Antoniu, SA; Azoicai, D	1
Casal, J; Martínez Benazet, J; Roig, J	1
Brollo, L; Di Qual, E; Dolcet, F; Furlanut, M; Lugatti, E; Pea, F; Talmassons, G	1
Iakovlev, SV; Iakovlev, VP	1
Gopal Rao, G; Mahankali Rao, CS; Starke, I	1
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K	1
Critchley, IA; Evangelista, AT; Jones, ME; Karlowsky, JA; Noel, GJ; Sahm, DF; Thornsberry, C	1
Burgmann, H; Kumbein, F; Lukas, A; Mayer, B; Oberbauer, R	1
Hamburger, RJ; Kays, MB; Lucksiri, A; Mueller, BA; Scott, MK; Sowinski, KM	1
Blosser-Middleton, RS; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C	1
Matsumoto, T; Odagiri, S; Uchino, K; Yamaguchi, H; Yokoyama, H	1
Alvarez-Lerma, F; Bermejo, B; León, C; Olaechea, P; Palomar, M; Sánchez, M	1
Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S	1
Chen, MJ; Hu, BJ; Li, HY; Liu, Y; Sun, ZY; Wang, H; Yu, YS	1
Andrade, S; Barth, A; Blosser-Middleton, RS; Jones, ME; Karlowsky, JA; Kiffer, CR; Mendes, C; Rossi, F; Sader, HS; Sahm, DF; Thornsberry, C	1
Furlanut, M; Pea, F	1
Blasi, F	1
Fish, DN	1
Brown, SD; Farrell, DJ; Morrissey, I	1
Hoepelman, I	1
Zubkov, MN	1
Romanovskiĭ, AG; Sinopal'nikov, AI	1
Hermsen, ED; Hovde, LB; Konstantinides, GN; Rotschafer, JC	1
Fuller, JD; Low, DE	1
Fritsche, TR; Jones, RN; Sader, HS	1
Ceydilek, B; Coban, S; Ekiz, F; Erden, E; Soykan, I	1
Byrns, K; Goldner, B; Makaryus, AN; Makaryus, MN; Natarajan, U; Singer, C	1
Sollet, JP	1
Cantón, R; Graninger, W; Lode, H; Milkovich, G	1
Asoh, N; Mizota, T; Nagatake, T; Oishi, K; Qin, L; Watanabe, H; Watanabe, K	1
Kahn, JB; Khashab, MM; Xiang, J	1
Budanov, SV; Ivanov, DV	1
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Omika, K; Sato, Y	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L	1
Min, ZS; Tan, C; Zhu, WY	1
Gibert, AE; Porta, FS	1
Bryson, HM; Davis, R	1
Kawai, T	1
Miyashita, Y; Nakamori, Y; Nakata, K; Nakatani, I	1
Odagiri, S	1
Ida, M; Iwata, M; Nagayama, M; Ogawa, H; Ono, T; Sato, A; Shirai, M; Shirai, T; Suda, T; Yasuda, K	1
Furukawa, K; Kawakami, K; Kono, H; Nagai, H; Shishido, H	1
Hoogkamp-Korstanje, JA	1
Andrews, JM; Brenwald, NP; Cunningham, B; Honeybourne, D; Jevons, G; Wise, R	1
Berman, AL; Chow, AT; Corrado, M; Dornseif, B; Drusano, GL; Fowler, CL; Natarajan, J; Preston, SL; Reichl, V	1
Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C	1
Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S	1
Andrews, JM; Wise, R	1
Lamb, HM; Langtry, HD	1
Fukayama, M; Inamatsu, T; Kita, Y; Masuda, Y; Yasuda, H; Yoshida, A	1
Redondo Sánchez, J	1
Alonso Manzanares, MA; García-Rodríguez, JA; Gutiérrez Zufiaurre, MN; Muñoz Bellido, JL	1
Fujita, A; Goya, T; Hirayama, S; Isaka, H; Koshiishi, Y; Miya, T; Ono, Y; Tanaka, R	1
Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K	1
Funato, T; Hongo, T; Igari, J; Iinuma, Y; Ishigo, S; Ishii, K; Ishii, M; Itoh, C; Iwata, M; Kaimori, M; Kaku, M; Kamihira, S; Kanda, M; Kashitani, F; Katoh, J; Kawahara, S; Kawamura, C; Kudoh, M; Kuwabara, M; Matsudou, Y; Matsushima, T; Miyashita, N; Miyazaki, S; Miyazaki, Y; Murakami, N; Nakagawa, K; Nakasone, I; Negayama, K; Niki, Y; Nisawataira, T; Oguri, T; Okada, J; Ono, J; Saito, Y; Sato, N; Taira, M; Takada, T; Takii, M; Tamaki, I; Tashiro, H; Tazawa, Y; Toyoshima, S; Tsujio, Y; Uehara, N; Ueno, K; Watanabe, N; Yamaguchi, K; Yamanaka, K; Yasujima, M; Yoshida, T	1
Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K	1
Shah, PM	1
Eda, T; Hosaka, M; Hoshino, K; Inoue, M; Kaieda, S; Kitasato, H; Kuga, A; Okamoto, R; Sato, Y; Seto, I	1
Garvin, CG; Jung, R; Martin, SJ	1
Ambler, J; Cardeñosa, O; Lemme, L; Lopez, H; Scarano, S; Smayevsky, J; Stepanik, D; Sucari, A; Vilches, V	1
Budanov, SV; Smirnova, LB; Vasil'ev, AN	1
Rossi, C; Sternon, J	1
Hutchinson, J	1
Aoki, N; Hayashi, S; Honma, C; Koda, Y; Nitta, I; Takasawa, T; Usuda, Y; Wakabayashi, N; Watanabe, K	1
Nakamori, Y; Nakata, K; Nakatani, T; Narui, K; Sugi, H; Tsuboi, E	1
Hara, K; Iwamoto, M; Kaku, M; Koga, H; Kohno, S; Kusano, S; Maesaki, S; Sakito, O; Sugawara, K; Tanaka, K	1

Reviews

28 review(s) available for levofloxacin and Infections, Respiratory

Article	Year
[CHARACTERISTICS OF LEVOFLOXACIN AND ITS CLINICAL APPLICATION (REVIEW)]. Georgian medical news, 2020, Issue:307 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Respiratory Tract Infections	2020
Clostridium colicanis bacteraemia in an asthmatic patient diagnosed as acute respiratory infection. Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:9 Topics: Aged; Anti-Bacterial Agents; Asthma; Bacteremia; Cefotaxime; Clostridium; Clostridium Infections; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Immunocompetence; Levofloxacin; Respiratory Tract Infections	2019
Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis. Expert review of respiratory medicine, 2015, Volume: 9, Issue:1 Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chronic Disease; Cystic Fibrosis; Humans; Levofloxacin; Lung; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Time Factors; Treatment Outcome	2015
[Infections in cystic fibrosis: Up-to-date]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016, Volume: 23, Issue:12S Topics: Child; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Early Medical Intervention; Guideline Adherence; Humans; Infant; Levofloxacin; Mycoses; Opportunistic Infections; Respiratory Tract Infections; Treatment Outcome	2016
[PK/PD profile and post-marketing surveillance of levofloxacin]. Le infezioni in medicina, 2009, Volume: 17 Suppl 5 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Kidney; Levofloxacin; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Ofloxacin; Product Surveillance, Postmarketing; Respiratory Tract Infections; Spondylitis	2009
Levofloxacin-induced radiation recall dermatitis: a case report and a review of the literature. Clinical breast cancer, 2010, Oct-01, Volume: 10, Issue:5 Topics: Anti-Bacterial Agents; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Radiodermatitis; Radiotherapy, Adjuvant; Respiratory Tract Infections	2010
Levofloxacin for the treatment of respiratory tract infections. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:8 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Treatment Outcome	2012
MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections. Expert opinion on investigational drugs, 2013, Volume: 22, Issue:2 Topics: Administration, Inhalation; Anti-Bacterial Agents; Chronic Disease; Clinical Trials as Topic; Drug Discovery; Drug Resistance, Bacterial; Humans; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Treatment Outcome	2013
[Levofloxacin in the treatment of respiratory infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2002, Volume: 47, Issue:8 Topics: Acute Disease; Anti-Infective Agents; Bronchitis, Chronic; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Sinusitis	2002
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16 Suppl 2 Topics: Administration, Oral; Anti-Infective Agents; Area Under Curve; Biological Availability; Case-Control Studies; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Maximum Tolerated Dose; Ofloxacin; Pneumonia, Bacterial; Reference Values; Respiratory Tract Infections	2004
Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs). Journal of chemotherapy (Florence, Italy), 2004, Volume: 16 Suppl 2 Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Treatment Outcome	2004
Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'. Expert review of anti-infective therapy, 2003, Volume: 1, Issue:3 Topics: Animals; Drug Resistance, Microbial; Humans; Levofloxacin; Ofloxacin; Quinolones; Respiratory Tract Infections; Staphylococcal Skin Infections	2003
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin]. Nederlands tijdschrift voor geneeskunde, 2004, Oct-23, Volume: 148, Issue:43 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Pneumonia; Quinolines; Respiratory Tract Infections	2004
[Efficacy and safety of levofloxacin in low respiratory tract infection]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:5 Topics: Anti-Bacterial Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dermatitis, Atopic; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Respiratory Tract Infections; Streptococcus pneumoniae	2004
[Levofloxacin: role and place in the treatment of infections of the lower respiratory tracts]. Terapevticheskii arkhiv, 2004, Volume: 76, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; Central Nervous System; Drug Resistance, Bacterial; Humans; Levofloxacin; Musculoskeletal System; Ofloxacin; Respiratory System; Respiratory Tract Infections	2004
A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-01, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Failure	2005
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin. International journal of antimicrobial agents, 2006, Volume: 28 Suppl 2 Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Community-Acquired Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Factors	2006
Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections. Current medical research and opinion, 2006, Volume: 22, Issue:10 Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections	2006
[Levofloxacin and other antibacterial drugs]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Dermatitis; Dosage Forms; Humans; Levofloxacin; Ofloxacin; Otitis Media; Respiratory Tract Infections; Sinusitis; Urinary Tract Infections	2006
Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 1994, Volume: 47, Issue:4 Topics: Administration, Oral; Aging; Bacteria; Bacterial Infections; Biological Availability; Drug Interactions; Female Urogenital Diseases; Half-Life; Humans; Levofloxacin; Male Urogenital Diseases; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections; Stereoisomerism	1994
Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 1998, Volume: 56, Issue:3 Topics: Animals; Anti-Infective Agents; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections	1998
New fluoroquinolone antibiotics. Drug and therapeutics bulletin, 1999, Volume: 37, Issue:1 Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Piperazines; Respiratory Tract Infections	1999
[Levofloxacin for prevalent infections in primary care medicine]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17 Suppl 1 Topics: Anti-Infective Agents; Bacterial Infections; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Primary Health Care; Respiratory Tract Infections; Urinary Tract Infections	1999
[The present and future of levofloxacin in the treatment of respiratory infections]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17 Suppl 1 Topics: Anti-Infective Agents; Clinical Trials as Topic; Humans; Levofloxacin; Models, Molecular; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae	1999
The use of levofloxacin in the treatment of respiratory tract infection. Journal of chemotherapy (Florence, Italy), 2000, Volume: 12 Suppl 4 Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Respiratory Tract Infections; Streptococcus pneumoniae	2000
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections. Drug safety, 2001, Volume: 24, Issue:3 Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Assessment; Skin Diseases, Bacterial; Urinary Tract Infections	2001
[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2001, Volume: 46, Issue:7 Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Urinary Tract Infections	2001
[Third and fourth generation fluoroquinolones]. Revue medicale de Bruxelles, 2001, Volume: 22, Issue:5 Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Belgium; Biological Availability; Drug Monitoring; Drug Resistance; Fluoroquinolones; Gemifloxacin; Humans; Intestinal Absorption; Levofloxacin; Moxifloxacin; Naphthyridines; Ofloxacin; Patient Selection; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors; Treatment Outcome	2001

Trials

12 trial(s) available for levofloxacin and Infections, Respiratory

Article	Year
Cost-effectiveness analysis of oral versus intravenous drip infusion of levofloxacin in the treatment of acute lower respiratory tract infection in Chinese elderly patients. Clinical interventions in aging, 2017, Volume: 12 Topics: Acute Disease; Administration, Oral; Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Respiratory Tract Infections	2017
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016, Volume: 15, Issue:5 Topics: Administration, Inhalation; Adult; Aerosols; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Levofloxacin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin; Treatment Outcome	2016
Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:5 Topics: Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; China; Dizziness; Drug Administration Schedule; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Nausea; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Sleep Initiation and Maintenance Disorders; Streptococcus pneumoniae; Treatment Outcome; Urinary Tract Infections; Withholding Treatment	2009
Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections. Journal of clinical pharmacology, 2010, Volume: 50, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Respiratory Mucosa; Respiratory Tract Infections	2010
Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial. Chemotherapy, 2012, Volume: 58, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dioxolanes; Disk Diffusion Antimicrobial Tests; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Piperazines; Respiratory Tract Infections; Treatment Outcome; Urinary Tract Infections; Young Adult	2012
Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:3 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Clostridioides difficile; Community-Acquired Infections; Diarrhea; Female; Humans; Levofloxacin; Male; Ofloxacin; Prospective Studies; Respiratory Tract Infections	2003
Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains. Epidemiology and infection, 2007, Volume: 135, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections	2007
Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections; Sputum	1995
Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections; Sputum; Treatment Outcome	1995
Clinical efficacy of levofloxacin in elderly patients with respiratory tract infections. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections	1995
Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Aged; Anti-Infective Agents; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections	1995
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA, 1998, Jan-14, Volume: 279, Issue:2 Topics: Adult; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections	1998

Other Studies

79 other study(ies) available for levofloxacin and Infections, Respiratory

Article	Year
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae	2007
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Adolescent; Adult; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Female; Gene Frequency; Genotype; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Respiratory Tract Infections	2007
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2007
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA	2009
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult	2010
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B	2010
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy. Journal of medicinal chemistry, 2012, Jan-26, Volume: 55, Issue:2 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cyclophosphamide; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Ribosomes; Sepsis; Stereoisomerism; Structure-Activity Relationship; Tetracycline Resistance; Tetracyclines	2012
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens. Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5 Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae	2013
Design, Synthesis, and Biological Evaluation of Novel 7-[(3 aS,7 aS)-3 a-Aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens. Journal of medicinal chemistry, 2018, 08-23, Volume: 61, Issue:16 Topics: Animals; Anti-Bacterial Agents; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; ERG1 Potassium Channel; Escherichia coli; Female; Humans; Macaca fascicularis; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred CBA; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae	2018
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections. Bioorganic & medicinal chemistry letters, 2022, 05-01, Volume: 63 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperidines; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae; Structure-Activity Relationship	2022
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-17, Volume: 75, Issue:Suppl 3 Topics: Animals; Anthrax; Anti-Bacterial Agents; Azithromycin; Bacillus anthracis; Clarithromycin; Disease Models, Animal; Levofloxacin; Macaca fascicularis; Respiratory Tract Infections	2022
Levofloxacin-induced acute rhabdomyolysis: A case report. International journal of clinical pharmacology and therapeutics, 2023, Volume: 61, Issue:12 Topics: Acute Kidney Injury; Female; Humans; Levofloxacin; Middle Aged; Respiratory Tract Infections; Rhabdomyolysis	2023
[Prescription of antibiotics in acute respiratory infections non-pneumonia in a private outpatient practice]. Revista medica de Chile, 2022, Volume: 150, Issue:8 Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Drug Prescriptions; Female; Humans; Levofloxacin; Male; Outpatients; Practice Patterns, Physicians'; Respiratory Tract Infections; Retrospective Studies	2022
Microbiological patterns of bacterial infections in tracheostomized children: Reducing uncertainty in continuous care. Pediatric pulmonology, 2023, Volume: 58, Issue:12 Topics: Adolescent; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Escherichia coli; Follow-Up Studies; Humans; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Staphylococcal Infections; Uncertainty	2023
Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection. Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Chronic Disease; Cystic Fibrosis; Female; Humans; Levofloxacin; Lung; Mice; Mice, Inbred BALB C; Respiratory Tract Infections	2020
Diphenhydramine and levofloxacin combination therapy against antimicrobial resistance in respiratory tract infections. Future microbiology, 2021, Volume: 16 Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Cricetinae; Diphenhydramine; Drug Resistance, Bacterial; Drug Synergism; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections	2021
Black hairy tongue cured concurrently with respiratory infection. Cleveland Clinic journal of medicine, 2017, Volume: 84, Issue:6 Topics: Anti-Bacterial Agents; Female; Humans; Levofloxacin; Middle Aged; Oral Hygiene; Respiratory Tract Infections; Smoking Cessation; Tongue; Tongue, Hairy; Treatment Outcome	2017
Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:10 Topics: Anti-Bacterial Agents; Base Sequence; DNA Gyrase; DNA Topoisomerase IV; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Mutation; Respiratory Tract Infections; Selection, Genetic; Sequence Analysis, DNA; Topoisomerase Inhibitors	2017
Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Animals; Anthrax; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Antitoxins; Bacillus anthracis; Bacterial Toxins; Drug Therapy, Combination; Female; Immunization, Passive; Immunoglobulin G; Immunologic Memory; Levofloxacin; Male; Rabbits; Random Allocation; Respiratory Tract Infections; Spores, Bacterial; Survival Analysis	2018
Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy. AAPS PharmSciTech, 2018, Volume: 19, Issue:3 Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Levofloxacin; Liposomes; Lung Diseases; Muramidase; Rats; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus	2018
Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro. MicrobiologyOpen, 2019, Volume: 8, Issue:5 Topics: Anti-Bacterial Agents; Biofilms; China; Gene Expression Profiling; Humans; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sequence Analysis, RNA; Staining and Labeling	2019
Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections. International journal of antimicrobial agents, 2013, Volume: 42, Issue:3 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Respiratory Tract Infections	2013
[Levofloxacin-induced autoimmune hepatitis. Description of a case]. Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1 Topics: Adrenal Cortex Hormones; Alanine Transaminase; Anti-Asthmatic Agents; Aspartate Aminotransferases; Asthma; Biopsy; Chemical and Drug Induced Liver Injury; Eosinophilia; Female; Hepatitis, Autoimmune; Humans; Levofloxacin; Liver; Middle Aged; Nasal Polyps; Prednisone; Recurrence; Respiratory Tract Infections	2014
Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Levofloxacin; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections; Risk Factors; Sputum; Stenotrophomonas maltophilia	2015
Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax. PloS one, 2014, Volume: 9, Issue:9 Topics: Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins, Intravenous; Levofloxacin; Male; Rabbits; Respiratory Tract Infections; Toxemia; Treatment Outcome	2014
Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genetic Variation; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Nalidixic Acid; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Sequence Analysis, DNA	2015
Impact of poor compliance with levofloxacin and moxifloxacin on respiratory tract infection antimicrobial efficacy: a pharmacokinetic/pharmacodynamic simulation study. International journal of antimicrobial agents, 2015, Volume: 45, Issue:1 Topics: Adult; Anti-Bacterial Agents; Fluoroquinolones; Haemophilus influenzae; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Models, Statistical; Moraxella catarrhalis; Moxifloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Failure; Young Adult	2015
Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2 Topics: Animals; Anthrax; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Levofloxacin; Male; Rabbits; Respiratory Tract Infections	2015
[Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2015, Volume: 38, Issue:1 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae	2015
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2016, Volume: 39, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Cefepime; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae	2016
Levofloxacin-induced rhabdomyolysis: a case report. Journal of medical case reports, 2016, Aug-24, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Creatine Kinase; Humans; Levofloxacin; Male; Middle Aged; Muscle Fatigue; Respiratory Tract Infections; Rhabdomyolysis; Treatment Outcome	2016
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Intensive Care Units; Length of Stay; Levofloxacin; Male; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Respiratory Tract Infections; Risk Factors; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination	2016
Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. Postgraduate medicine, 2002, Volume: 112, Issue:3 Suppl Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Doxycycline; Drug Resistance, Multiple, Bacterial; Humans; Kentucky; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome; United States	2002
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007]. The Japanese journal of antibiotics, 2009, Volume: 62, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gastrointestinal Diseases; Humans; Japan; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Time Factors; Urinary Tract Infections	2009
Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection. Infection and immunity, 2010, Volume: 78, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cells, Cultured; Colony Count, Microbial; Cytokines; Female; Francisella tularensis; Humans; Immunologic Factors; Levofloxacin; Lung; Mice; Mice, Inbred BALB C; Monocytes; Neutrophils; Ofloxacin; Poly I-C; Respiratory Tract Infections; Survival Analysis; Toll-Like Receptor 3; Tularemia	2010
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. BMC microbiology, 2010, Apr-21, Volume: 10 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dioxolanes; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Respiratory Tract Infections; Selection, Genetic; Urinary Tract Infections	2010
A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06). The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Anti-Bacterial Agents; Canada; Ciprofloxacin; Drug Utilization; Fluoroquinolones; Humans; Influenza, Human; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Factors; Socioeconomic Factors	2010
[Levofloxacin and other fluoroquinolones in therapy of respiratory tract infections]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2011, Volume: 30, Issue:176 Topics: Administration, Oral; Anti-Bacterial Agents; Biological Availability; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections	2011
Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95 Suppl 2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Respiratory Tract Infections; Thailand; Urinary Tract Infections	2012
Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax. Clinical and vaccine immunology : CVI, 2012, Volume: 19, Issue:8 Topics: Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antigens, Bacterial; Bacterial Toxins; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunoglobulin G; Levofloxacin; Ofloxacin; Post-Exposure Prophylaxis; Rabbits; Recombinant Proteins; Respiratory Tract Infections; Survival Analysis; Treatment Outcome; Vaccination	2012
[The use of levofloxacin for the empirical treatment of exacerbations of mild, chronic COPD: Is it justified in under-65-years-old patients with no comorbidity?]. Archivos de bronconeumologia, 2002, Volume: 38, Issue:11 Topics: Anti-Infective Agents; Humans; Levofloxacin; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections	2002
Pharmacokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Area Under Curve; Cohort Studies; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Ofloxacin; Respiratory Tract Infections; Statistics, Nonparametric	2003
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections	2002
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Azithromycin; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Ofloxacin; Pneumococcal Infections; Prospective Studies; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2003
The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections. Wiener medizinische Wochenschrift (1946), 2003, Volume: 153, Issue:7-8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Cluster Analysis; Cohort Studies; Community-Acquired Infections; Comorbidity; Female; Haemophilus Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Respiratory Tract Infections; Treatment Outcome	2003
Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 42, Issue:2 Topics: Adult; Aged; Anti-Infective Agents; Bacteria; Cellulose; Chromatography, High Pressure Liquid; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Levofloxacin; Male; Membranes, Artificial; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Renal Dialysis; Respiratory Tract Infections	2003
The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. Diagnostic microbiology and infectious disease, 2003, Volume: 47, Issue:4 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Global Health; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Sensitivity and Specificity; Streptococcus pneumoniae	2003
[Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Body Temperature; Drug Administration Schedule; Fever; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Quality of Life; Referral and Consultation; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome	2003
[Observational study investigating the use of levofloxacin in ICU patients]. Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Arrhythmias, Cardiac; Bacterial Infections; Chemical and Drug Induced Liver Injury; Community-Acquired Infections; Comorbidity; Critical Care; Cross Infection; Diarrhea; Drug Resistance; Drug Therapy, Combination; Drug Utilization; Female; Humans; Infusions, Parenteral; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Respiration, Artificial; Respiratory Tract Infections; Spain	2004
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. Chemotherapy, 2004, Volume: 50, Issue:1 Topics: Abdominal Injuries; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Aerobic; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Wound Infection	2004
[Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2004, Volume: 27, Issue:3 Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child, Preschool; China; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Ofloxacin; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae	2004
Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:6 Topics: Anti-Bacterial Agents; Brazil; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Population Surveillance; Respiratory Tract Infections; Streptococcus pneumoniae	2004
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study. Journal of clinical microbiology, 2004, Volume: 42, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Population Surveillance; Prevalence; Respiratory Tract Infections; Streptococcus pneumoniae; United States	2004
Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Mutation; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae	2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. Diagnostic microbiology and infectious disease, 2005, Volume: 52, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Respiratory Tract Infections; Streptococcus pneumoniae	2005
Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:10 Topics: Anti-Bacterial Agents; Fatal Outcome; Female; Hepatic Encephalopathy; Hepatitis B, Chronic; Humans; Levofloxacin; Liver; Middle Aged; Ofloxacin; Respiratory Tract Infections	2005
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? Southern medical journal, 2006, Volume: 99, Issue:1 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Levofloxacin; Long QT Syndrome; Male; Ofloxacin; Prognosis; Prospective Studies; Prostatitis; Respiratory Tract Infections; Severity of Illness Index; Urinary Tract Infections	2006
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin. International journal of antimicrobial agents, 2006, Volume: 28 Suppl 2 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Factors	2006
[Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections]. The Japanese journal of antibiotics, 2007, Volume: 60, Issue:2 Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Levofloxacin; Moraxella catarrhalis; Naphthyridines; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections; Streptococcus	2007
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC infectious diseases, 2007, Sep-21, Volume: 7 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin	2007
Recall urticaria related to levofloxacin. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:5 Topics: Adult; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Male; Ofloxacin; Respiratory Tract Infections; Urticaria	2008
Hypoglycemia and levofloxacin: a case report. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Apr-01, Volume: 46, Issue:7 Topics: Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Levofloxacin; Ofloxacin; Respiratory Tract Infections	2008
Levofloxacin in patients with severe respiratory tract infection. Drugs, 1995, Volume: 49 Suppl 2 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections	1995
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:3 Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Respiratory Tract Infections	1997
Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:4 Topics: Administration, Oral; Anti-Infective Agents; Biopsy; Bronchoscopy; Female; Fiber Optic Technology; Humans; Levofloxacin; Lung; Male; Ofloxacin; Respiratory Tract Infections	1997
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States	1997
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4 Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae	1998
A comparison of the activity of ciprofloxacin and levofloxacin with other agents against respiratory tract pathogens. Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:4 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae	1998
[Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1999, Volume: 36, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Respiratory Tract Infections; Seizures	1999
[Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:11 Topics: Adult; Aged; Chronic Disease; Female; Humans; Levofloxacin; Lung; Male; Middle Aged; Ofloxacin; Pneumonia; Respiratory Tract Infections; Saliva; Time Factors	1999
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:1 Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	2000
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:6 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Respiratory Tract Infections; Urinary Tract Infections	2000
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus	2000
[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:9 Topics: Anti-Infective Agents; Bacteria; Dioxolanes; Drug Resistance, Microbial; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Piperazines; Quinolones; Respiratory Tract Infections; Sepsis	2000
Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens. International journal of antimicrobial agents, 2001, Volume: 18, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Community-Acquired Infections; Fluoroquinolones; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes	2001
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. The New England journal of medicine, 2002, Jul-04, Volume: 347, Issue:1 Topics: Anti-Infective Agents; Canada; Drug Resistance, Bacterial; Drug Utilization; Hospitals; Humans; Levofloxacin; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae	2002
[Clinical pharmacology and efficacy of levofloxacin in elderly patients]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:5 Topics: Aged; Aged, 80 and over; Drug Evaluation; Female; Humans; Kidney Diseases; Levofloxacin; Male; Ofloxacin; Respiratory Tract Infections	1992
[Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:5 Topics: Aged; Chronic Disease; Drug Evaluation; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections; Sputum	1992
[Laboratory and clinical studies on levofloxacin]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:5 Topics: Adult; Aged; Bacteria; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections; Sputum	1992